Gyre Therapeutics Inc. (GYRE) — Financial Flexibility Index
Gyre Therapeutics Inc. (GYRE) has a Financial Flexibility Index of 0.13x as of March 2026. Free cash flow of $3.36 Million (operating CF $3.18 Million minus capex $178.00K) represents 0% of total liabilities ($25.03 Million). Check GYRE strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gyre Therapeutics Inc. Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Gyre Therapeutics Inc. across 22 annual periods. See Gyre Therapeutics Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Gyre Therapeutics Inc. (2004–2025)
Year-by-year free cash flow to debt coverage for Gyre Therapeutics Inc.. For the full company profile including market capitalisation, see market value of Gyre Therapeutics Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | $2.20 Million | $1.01 Million | $23.85 Million | ▲ +585.6% |
| 2024 | -0.02x | $-513.00K | $-3.64 Million | $27.00 Million | ▼ -105.7% |
| 2023 | 0.34x | $34.48 Million | $25.89 Million | $102.59 Million | ▼ -73.1% |
| 2022 | 1.25x | $15.68 Million | $10.68 Million | $12.54 Million | ▲ +122.0% |
| 2021 | -5.69x | $-82.92 Million | $-83.75 Million | $14.57 Million | ▼ -95.0% |
| 2020 | -2.92x | $-54.78 Million | $-55.05 Million | $18.78 Million | ▼ -102.4% |
| 2019 | -1.44x | $-43.55 Million | $-43.61 Million | $30.22 Million | ▲ +74.6% |
| 2018 | -5.66x | $-28.18 Million | $-28.55 Million | $4.97 Million | ▼ -148.5% |
| 2017 | -2.28x | $-19.92 Million | $-19.94 Million | $8.74 Million | ▼ -178.7% |
| 2016 | -0.82x | $-18.00 Million | $-18.47 Million | $22.02 Million | ▼ -65.3% |
| 2015 | -0.49x | $-18.85 Million | $-19.12 Million | $38.10 Million | ▲ +95.8% |
| 2014 | -11.83x | $-34.48 Million | $-34.48 Million | $2.91 Million | ▼ -228.9% |
| 2013 | -3.60x | $-40.52 Million | $-40.61 Million | $11.26 Million | ▲ +23.1% |
| 2012 | -4.68x | $-63.91 Million | $-64.24 Million | $13.66 Million | ▼ -376.5% |
| 2011 | -0.98x | $-82.29 Million | $-83.72 Million | $83.84 Million | ▼ -218.5% |
| 2010 | 0.83x | $141.61 Million | $138.30 Million | $170.94 Million | ▲ +961.7% |
| 2009 | -0.10x | $-24.07 Million | $-24.27 Million | $250.39 Million | ▲ +84.9% |
| 2008 | -0.64x | $-26.21 Million | $-28.26 Million | $41.18 Million | ▼ -201.3% |
| 2007 | 0.63x | $29.78 Million | $24.84 Million | $47.38 Million | ▲ +216.7% |
| 2006 | -0.54x | $-8.82 Million | $-9.89 Million | $16.37 Million | ▼ -294.6% |
| 2005 | -0.14x | $-26.00 Million | $-26.25 Million | $190.48 Million | ▼ -1.4% |
| 2004 | -0.13x | $-24.38 Million | $-25.04 Million | $181.17 Million | — |